Trial Information
Summary: A phase II trial of cisplatin, pemetrexed and bevacizumab in untreated malignant mesothelioma
The primary objective of this phase II trial in mesothelioma is to evaluate READ MORE http://www.centerwatch.com/patient/studies/stu92726.html